Top

Published in:

01-02-2017 | Gynecologic Oncology

The impact of total parenteral nutrition on postoperative recovery in patients treated for advanced stage ovarian cancer

Authors: Alberto A. Mendivil, Mark A. Rettenmaier, Lisa N. Abaid, John V. Brown III, Kristina M. Mori, Bram H. Goldstein

Published in: Archives of Gynecology and Obstetrics | Issue 2/2017

Abstract

Objectives

Total parenteral nutrition (TPN) presumably benefits cancer patients although reports have disputed the significance of this nutritional intervention. We sought to compare the postoperative outcomes of ovarian cancer patients treated with either TPN or conservative management.

Methods

We retrospectively evaluated the impact of TPN and conservative management in ovarian cancer patients who underwent debulking surgery and a bowel resection. The primary study variables encompassed patient time until restoration of bowel function, number of postoperative complications and duration of hospital stay.

Results

There were 147 subjects who were selected for this study. The patients who were treated with TPN (n = 69) demonstrated a longer time until restoration of bowel function (5.77 vs. 4.70 days; P < 0.001), experienced lower pre-operative albumin levels (2.22 vs. 2.97 g/dL; P < 0.001) and endured a significantly longer hospital stay (11.46 vs. 7.14 days; P < 0.001) compared to the conservative management (n = 78) cohort.

Conclusions

Postoperative TPN in ovarian cancer patients may be inadvisable because of the increased risk for complications. Moreover, in the hypoalbuminemic patients, TPN may have not only delayed their postoperative recovery and increased hospital stay duration, but further precipitated the manifestation of nosocomial sequelae.

de Luis DA, Culebras JM, Aller R, Eiros-Bouza JM (2014) Surgical infection and malnutrition. Nutr Hosp 30:509–513PubMed

Nussbaum DP, Penne K, Stinnett SS, Speicher PJ, Cocieru A et al (2015) A standardized care plan is associated with shorter hospital length of stay in patients undergoing pancreaticoduodenectomy. J Surg Res 193:237–245CrossRefPubMed

Melbert RB, Kimmins MH, Isler JT, Billingham RP, Lawton D et al (2002) Use of a critical pathway for colon resections. J Gastrointest Surg 6:745–752CrossRefPubMed

Hoda D, Jatoi A, Burnes J, Loprinzi C, Kelly D (2005) Should patients with advanced, incurable cancers ever be sent home with total parenteral nutrition? A single institution’s 20-year experience. Cancer 103:863–868CrossRefPubMed

Balogun N, Forbes A, Widschwendter M, Lanceley A (2012) Noninvasive nutritional management of ovarian cancer patients: beyond intestinal obstruction. Int J Gynecol Cancer 22:1089–1095CrossRefPubMed

Baker J, Janda M, Graves N, Bauer J, Banks M et al (2015) Quality of life after early enteral feeding versus standard care for proven or suspected advanced epithelial ovarian cancer: results from a randomised trial. Gynecol Oncol 137:516–522CrossRefPubMed

Laky B, Janda M, Kondalsamy-Chennakesavan S, Cleghorn G, Obermair A (2010) Pretreatment malnutrition and quality of life—association with prolonged length of hospital stay among patients with gynecological cancer: a cohort study. BMC Cancer 10:232CrossRefPubMedPubMedCentral

Minig L, Biffi R, Zanagnolo V, Attanasio A, Beltrami C et al (2009) A. Early oral versus “traditional” postoperative feeding in gynecologic oncology patients undergoing intestinal resection: a randomized controlled trial. Ann Surg Oncol 16:1660–1668CrossRefPubMed

Klein S, Simes J, Blackburn GL (1986) Total parenteral nutrition and cancer clinical trials. Cancer 58:1378–1386CrossRefPubMed

10.

Tixier H, Fraisse J, Chauffert B, Mayer F, Causeret S, Loustalot C et al (2010) Evaluation of pelvic posterior exenteration in the management of advanced-stage ovarian cancer. Arch Gynecol Obstet 281:505–510CrossRefPubMed

11.

Barber MD, Fearon KC, Delmore G, Loprinzi CL (1989) Should cancer patients with incurable disease receive parenteral or enteral nutritional support? Eur J Cancer 34:279–285CrossRef

12.

Rettenmaier MA, Abaid LN, Brown JV 3rd, Mendivil AA, Micha JP et al (2014) The incidence of postprandial nausea and nutritional regression in gynecologic cancer patients following intestinal surgery: a retrospective cohort study. Int J Surg 12:783–787CrossRefPubMed

13.

Chi DS, Eisenhauer EL, Lang J, Huh J, Haddad L, Abu-Rustum NR et al (2006) What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? Gynecol Oncol 103:559–564CrossRefPubMed

14.

Brard L, Weitzen S, Strubel-Lagan SL, Swamy N, Gordinier ME et al (2006) The effect of total parenteral nutrition on the survival of terminally ill ovarian cancer patients. Gynecol Oncol 103:176–180CrossRefPubMed

15.

Gerardi MA, Santillan A, Meisner B, Zahurak ML, Diaz Montes TP et al (2008) A clinical pathway for patients undergoing primary cytoreductive surgery with rectosigmoid colectomy for advanced ovarian and primary peritoneal cancers. Gynecol Oncol 108:282–286CrossRefPubMed

16.

National Institute of Health (2010) National Cancer Institute. CTCAE: common terminology criteria for adverse events, version 4.03. Washington

17.

Shamberger RC, Brennan MF, Goodgame JT Jr, Lowry SF, Maher MM et al (1984) A prospective, randomized study of adjuvant parenteral nutrition in the treatment of sarcomas: results of metabolic and survival studies. Surgery 96:1–13PubMed

18.

American College of Physicians (1989) Parenteral nutrition in patients receiving cancer chemotherapy. American College of Physicians. Ann Intern Med 110:734–736CrossRef

19.

Peter JV, Moran JL, Phillips-Hughes J (2005) A metaanalysis of treatment outcomes of early enteral versus early parenteral nutrition in hospitalized patients. Crit Care Med 33:213–220CrossRefPubMed

20.

Delgado-Rodríguez M, Medina-Cuadros M, Gómez-Ortega A, Martínez-Gallego G, Mariscal-Ortiz M et al (2002) Cholesterol and serum albumin levels as predictors of cross infection, death, and length of hospital stay. Arch Surg 137:805–812CrossRefPubMed

21.

Lohsiriwat V, Chinswangwatanakul V, Lohsiriwat S, Akaraviputh T, Boonnuch W et al (2007) Hypoalbuminemia is a predictor of delayed postoperative bowel function and poor surgical outcomes in right-sided colon cancer patients. Asia Pac J Clin Nutr 16:213–217PubMed

22.

Ryan AM, Hearty A, Prichard RS, Cunningham A, Rowley SP et al (2007) Association of hypoalbuminemia on the first postoperative day and complications following esophagectomy. J Gastrointest Surg 11:1355–1360CrossRefPubMed

23.

Ataseven B, du Bois A, Reinthaller A, Traut A, Heitz F, Aust S et al (2015) Pre-operative serum albumin is associated with post-operative complication rate and overall survival in patients with epithelial ovarian cancer undergoing cytoreductive surgery. Gynecol Oncol 138:560–565CrossRefPubMed

24.

Kathiresan AS, Brookfield KF, Schuman SI, Lucci JA 3rd (2010) Malnutrition as a predictor of poor postoperative outcomes in gynecologic cancer patients. Arch Gynecol Obstet 284:445–451CrossRefPubMed

25.

Ionescu D, Tibrea C, Puia C (2013) Pre-operative hypoalbuminemia in colorectal cancer patients undergoing elective surgery—a major risk factor for postoperative outcome. Chirurgia 108:822–828PubMed

26.

Braga M, Ljungqvist O, Soeters P, Fearon K, Weimann A et al (2009) ESPEN guidelines on parenteral nutrition: surgery. Clin Nutr 28:378–386CrossRefPubMed

27.

Chambrier C, Sztark F, Société Francophone de nutrition clinique et métabolisme (SFNEP), Société française d’anesthésie et réanimation (SFAR) (2012) French clinical guidelines on perioperative nutrition. Update of the 1994 consensus conference on perioperative artificial nutrition for elective surgery in adults. J Visc Surg 149:e325–e336CrossRefPubMed

Title: The impact of total parenteral nutrition on postoperative recovery in patients treated for advanced stage ovarian cancer
Authors: Alberto A. Mendivil
Mark A. Rettenmaier
Lisa N. Abaid
John V. Brown III
Kristina M. Mori
Bram H. Goldstein
Publication date: 01-02-2017
Publisher: Springer Berlin Heidelberg
Published in: Archives of Gynecology and Obstetrics / Issue 2/2017
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-016-4227-2

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

The impact of total parenteral nutrition on postoperative recovery in patients treated for advanced stage ovarian cancer

Abstract

Objectives

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Objectives

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 2/2017

The number of cycles of neoadjuvant chemotherapy is associated with prognosis of stage IIIc–IV high-grade serous ovarian cancer

Investigating vaginal bleeding in postmenopausal women found to have an endometrial thickness of equal to or greater than 10 mm on ultrasonography

Perivaginal benign masses: diagnosis and therapy in a series of 66 women

Does alcohol consumption modify the risk of endometrial cancer? A dose–response meta-analysis of prospective studies

Maternal lipid profile and the relation with spontaneous preterm delivery: a systematic review

European Network of Trainees in Obstetrics and Gynaecology: experiences from the 2016 exchange programme in Turin, Italy